This is an old revision of the document!


Bert de Brock, Tommi Tervonen, Hans Hillege and Pieter de Graeff

Current Status and Future Perspectives of Drug Information Systems

The information lifecycle of a drug starts already during the drug discovery phase and continues far into the future in prescription- and adverse-effect databases. In this paper, we describe the past literature and existing technology of Drug Information Systems (DIS). We develop a mapping of DIS to the phased drug lifecycle taking into account the system information contents. The mapping shows that currently there is a lack of DIS providing efficacy- and safety data in a suitable format. This lack severely hinders the possibility of physicians, researchers, as well as regulatory authorities and the pharmaceutical industry, to make quantitative analyses of efficacy and safety over a wide range of drugs.

Back